Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3714

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3714 3)

Packaging label for Atorvastatin Calcium 20 mg tablets from NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets, film-coated, oval and biconvex white to off-white with tablet debossed markings. Includes multiple barcodes, product number P1915030, and storage instructions to keep at controlled temperature 68-77°F. The label also shows NDC 68071-3714-3 and manufacturing details from Amora Pharma Pvt. Ltd., Telangana, India.*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium as shown in the image, depicting the molecular configuration including the calcium ion complex.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph depicting the cumulative incidence percentage over time (in years) comparing Atorvastatin treatment to placebo. The graph shows lower cumulative incidence for Atorvastatin compared to placebo across a 3.5-year period.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph showing cumulative hazard percentage over time (in years) comparing Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The Atorvastatin group has a lower hazard curve compared to placebo, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p-value of 0.001 indicated on the graph.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph depicting the time to first major cardiovascular endpoint over a period of 5 years. It compares the event rates between atorvastatin 10 mg and atorvastatin 80 mg, showing a lower risk for the 80 mg dose with a hazard ratio of 0.78 (95% CI 0.69 to 0.89) and a statistically significant p-value of 0.0002.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.